Use of positive expiratory pressure during six minute walk test: Results in patients with moderate to severe chronic obstructive pulmonary disease

Multidisciplinary Respiratory Medicine

Volumn 8, Issue 3, 2013, Pages

  Nicolini, Antonello ^a   Merliak, Federico ^a   Barlascini, Cornelius ^b  

^a Hospital of Sestri Levante   (Italy)

^b Department of Anatomy   (Italy)

Author keywords

Moderate severe chronic obstructive pulmonary disease; Positive expiratory pressure device; Six minute walk test

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; TIOTROPIUM BROMIDE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROL GROUP; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; POSITIVE END EXPIRATORY PRESSURE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 84876947153     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-8-19     Document Type: Article

References (32)

1. Acquistapace F, Piepoli M: The walking test: use in clinical practice. Monaldi Arch Chest Dis 2009, 72:3-9.
2. Chetta A, Pisi G, Aiello M, Tzani P, Olivieri D: The walking capacity assessment in the respiratory patient. Respiration 2009, 77:361-367.
3. Clini EM, Crisafulli E: Exercise capacity as a pulmonary rehabilitation outcome. Respiration 2009, 77:121-128.
4. Saetta M, Finkenstein R, Coslo MG: Morphological and cellular basis for air flow limitation in smokers. Eur Respir J 1994, 7:1505-1515. (Pubitemid 24268340)
5. Carter R, Holiday DB, Stocks J, Tiep B: Peak physiologic responses to arm and leg ergometry in male and female patients with airflow obstruction. Chest 2000, 124:511-518.
6. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ: Exercise capacity and ventilator, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992, 146:935-940.
7. Moga AM, de Marchie M, Saey D, Spahija J: Mechanisms of non-pharmacologic adjunct therapies used during exercise in COPD. Respir Med 2012, 106:614-626.
8. Marin JM, Carrizo SJ, Gascon M, Sanchez A, Gallego B, Celli BR: Inspiratory capacity, dynamic hyperinflation, brethlessness, and exercise performance during the 6-minute walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163: 1395-1399. (Pubitemid 32506605)
9. Martin AD, Davenport PW: Extrinsic threshold PEEP reduces post-exercise dyspnea in COPD patients: a placebo-controlled double-blind cross-over study. Cardiopulm Phys Ther J 2011, 22(3):5-10.
10. Maltais F, Reissman H, Gottfried SB: Pressure support reduces inspiratory effort and dyspnea during exercise in chronic airflow obstruction. Am J Respir Crit Care Med 1995, 151:1027-1033.
11. Petrof BJ, Calderini E, Gottfried SB: Effect of CPAP on respiratory effort and dyspnea during exercise in severe COPD. J Appl Physiol 1990, 69:79-88.
12. Kyroussis D, Polkey MI, Hamnegard CH, Mills GH, Green M, Moxham J: Respiratory muscle activity in patients with COPD walking to exhaustion with and without pressure support. Eur Respir J 2000, 15:649-655. (Pubitemid 30196290)
13. Padkao T, Boonsawat W, Chulee UJ: Conical-PEP is safe, reduces lung hyperinflation and contributes to improved exercise endurance in patients with COPD:a randomized cross-over trial. J Physiother 2010, 56:33-39.
14. Miller MR, Hankinson J, Brusaco V, Burgos F, Casaburi R, Coates A, Crapo R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J 2005, 26(2):319-338. (Pubitemid 41079078)
15. Chadra D, Wise RA, Kulkarni HS, Benzo RP, Criner G, Make B, Slivka WA, Ries AL, Reilly JJ, Martinez FJ, Sciurba FC, NETT Research Group: Optimizing the 6-min walk test as a measure of exercise capacity. Chest 2012, 142(6):1545-1552.
16. Hernandes NA, Wouters EFM, Meijer K, Annegarn J, Pitta F, Spruit MA: Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J 2011, 38:261-267.
17. Casanova C, Celli BR, Barna P, Casas A, Cote C, de Torres JP, Jardim J, Lopez MV, Marin JM, Montes de Oca M, Pinto-Plata V, Aguirre-Jaime A, Six Minute Walk Distance Project (ALAT): The 6-min walk test distance in healthy subjects:reference standards from seven countries. Eur Respir J 2011, 37:150-156.
18. van der Schans CP, de Jong W, de Vries G, Kaan WA, Postma DS, Koeter GH, van der Mark TW: Effects of positive expiratory pressure breathing during exercise in patients with COPD. Chest 1995, 105:782-789. (Pubitemid 24088457)
19. Christensen EF, Jensen RH, Schonemann NK, Petersen KD: Flow-dependent properties of positive expiratory pressure devices. Arch Chest Dis 1995, 50(2):150-153.
20. ATS statement: Guidelines for six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117.
21. O' Donnel DE, Webb KA: The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol 2008, 105:753-755.
22. Cazzola M, Biscione GL, Pasqua F, Crigna G, Appodia M, Cardaci V, Ferri L: Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD. Respir Med 2008, 102:1425-1430.
23. Nicolini A: Short term effect of tiotropium on COPD patients treated with long acting bronchodilators. Tanaffos 2012, 11(1):26-31.
24. Menadue C, Alison JA, Piper AJ, Flunt D, Ellis ER: Bilevel ventilation during exercise in acute on chronic respiratory failure: a preliminary study. Respir Med 2010, 104:219-227.
25. Kohnlein T, Schonheit-Kenn U, WinterKamp S, Weite T, Kenn K: Noninvasive ventilation in pulmonary rehabilitation of COPD patients. Respir Med 2009, 103:1329-1336.
26. Menadue C, Alison J, Piper A, Flunt D, Ellis ER: Non-invasive ventilation during arm exercise and ground walking in patients with chronic hypercapnic respiratory failure. Respirology 2009, 14:251-259.
27. Costes F, Agresti A, Court-Fortune I, Roche F, Vergnon JM, Barthelemy JC: Non invasive ventilation during exercise training improves exercise tolerance in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2003, 23(4):307-313. (Pubitemid 36951170)
28. Wouters EFM: Non pharmacological modulation of dynamic hyperinflation. Eur Respir Rev 2006, 15:90-96.
29. Haeffener MP, Ferreira GM, MennaBarreto SS, Arena R, Dall'Ago P: Incentive spirometry with expiratory positive airway pressure reduces pulmonary complications, improves pulmonary function and 6-minute walk distance in patients undergoing coronary artery bypass graft surgery. Am J Heart 2008, 156:900. e1-900. e8.
30. Oliveira CC, Carrascosa CR, Borghi-Silva A, Berton DC, Queiroga F Jr, Ferreira EM, Nery LE, Neder JA, et al: Influence of respiratory pressure support on hemodynamics and exercise tolerance in patients with COPD. Eur J Appl Physiol 2010, 109:681-689.
31. Monteiro MB, Berton DC, Moreira FM, Menna-Barreto SS, ZimermannTeixera PJ: Effects of expiratory positive airway pressure on dynamic hyperinflation during exercise in patients with COPD. Respir Care 2012, 57(9):1405-1412.
32. Callens E, Graba S, Gillet-Juvin C, Essalhi M, Bidaud-Chevallier B, Peiffer C, Mahut B, Delclaux C: Measurement of dynamic hyperinflation after a 6-minute walk test in patients with COPD. Chest 2009, 136: 1466-1472.